1. Home
  2. HUBC vs CANF Comparison

HUBC vs CANF Comparison

Compare HUBC & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HUBC

Hub Cyber Security Ltd.

HOLD

Current Price

$1.00

Market Cap

6.6M

Sector

N/A

ML Signal

HOLD

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

BUY

Current Price

$2.14

Market Cap

6.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
HUBC
CANF
Founded
2017
1994
Country
Israel
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
6.7M
IPO Year
2022
2011

Fundamental Metrics

Financial Performance
Metric
HUBC
CANF
Price
$1.00
$2.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 260.8K
54.8K
Earning Date
11-11-2026
09-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.17
52 Week High
$8.68
$10.40

Technical Indicators

Market Signals
Indicator
HUBC
CANF
Relative Strength Index (RSI) 42.11 33.02
Support Level $0.27 $0.17
Resistance Level $1.74 $2.39
Average True Range (ATR) 0.73 0.06
MACD -0.45 0.03
Stochastic Oscillator 1.50 5.44

Price Performance

Historical Comparison
HUBC
CANF

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in developing reliable quality assurance systems that support process and product enhancement and also operates in the industry of secured data fabric. The company serves various organizations and institutions operating in the security, electronics, aviation, telecommunications, and banking. The company has two operating segments: Product and Technology Segment and Professional Services Segment. The majority of revenue comes from the professional services segment, which provides data and cybersecurity and system security and reliability solutions and related services such as consulting, planning, integrating and ongoing servicing of cybersecurity, risk management, reliability and security projects and fully managed corporate cybersecurity services.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: